Connect with us

Crowdfunding

Revo Foods Raises €1.2M to Scale Sustainable Protein with 3D Food Tech

Revo Foods launched a crowdfunding campaign on FunderNation, raising €1.2 million to expand its plant-based protein business. Despite market challenges, the company aims to boost appeal and scale operations using its 3D food extrusion technology. Funds will enhance production, marketing, and tech development, with a goal of reaching profitability by 2026 through sustainable mycoprotein innovations.

Published

on

Revo Foods

Revo Foods has launched a crowdfunding campaign on FunderNation to support its growth and expansion in the plant-based protein market. According to the latest information, the company has already raised €1.2 million from nearly 60 investors.

The crowdfunding campaign follows strong sales growth. In March, Revo Foods reported its highest sales ever. However, the company acknowledged that the entire alternative protein sector is struggling to gain traction with consumers. Despite these challenges, Revo Foods remains committed to refining its message and reaching a wider audience.

“We haven’t yet made our products attractive enough to mainstream consumers to make them switch to sustainable foods. But that’s not a reason to give up. It’s a reason to step up our game,” explains Revo Foods.

Revo Foods plans production expansion with advanced technology

The funds will help the company expand production at its recently opened THE TASTE FACTORY, powered by Revo Foods’ proprietary 3D food extrusion technology. This technology has enabled the company to launch six new products in the last six months, including plant-based fish alternatives such as THE FILET — inspired by salmon; EL BLANCO — inspired by black cod; and THE PRIME CUT, which differentiates itself from traditional animal products by using high-quality plant-based proteins.

These innovations are based on mycoprotein, a fermented fungal protein that offers a complete amino acid profile, is rich in protein and fiber, and has a low environmental impact. Revo Foods points out that mycoprotein requires less processing than other plant-based proteins such as soy or pea, making it a more sustainable alternative for consumers seeking healthier and more environmentally friendly options.

The crowdfunding funds will be used to expand production capacity, improve marketing efforts, and further develop 3D printing technology. Revo Foods plans to reach profitability by 2026, focusing on increasing production efficiency, reducing costs, and scaling operations to meet the growing demand for plant-based alternatives.

__

(Featured image by Michael Wave via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in vegconomist. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

J. Frank Sigerson is a business and financial journalist primarily covering crypto, cannabis, crowdfunding, technology, and marketing. He also writes about the movers and shakers in the stock market, especially in biotech, healthcare, mining, and blockchain. In the past, he has shared his thoughts on IT and design, social media, pop culture, food and wine, TV, film, and music. His works have been published in Investing.com, Equities.com, Seeking Alpha, Mogul, Small Cap Network, CNN, Technology.org, among others.

Continue Reading